BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 27588391)

  • 1. Regulation of matrix metalloproteinases (MMPs) expression and secretion in MDA-MB-231 breast cancer cells by LIM and SH3 protein 1 (LASP1).
    Endres M; Kneitz S; Orth MF; Perera RK; Zernecke A; Butt E
    Oncotarget; 2016 Sep; 7(39):64244-64259. PubMed ID: 27588391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
    Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
    Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration.
    Hailer A; Grunewald TG; Orth M; Reiss C; Kneitz B; Spahn M; Butt E
    Oncotarget; 2014 Jun; 5(12):4144-4153. PubMed ID: 24980827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-203 inhibits invasion and induces apoptosis of laryngeal cancer cells via targeting LASP1.
    Tan J; Jing YY; Han L; Zheng HW; Shen JX; Zhang LH; Yu LS
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6350-6357. PubMed ID: 30338803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of matrix metalloproteinases mediates thromboxane A2-induced invasion in lung cancer cells.
    Li X; Tai HH
    Curr Cancer Drug Targets; 2012 Jul; 12(6):703-15. PubMed ID: 22515524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
    Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of LIM and SH3 protein 1 in renal clear cell carcinoma and its effects on invasion and migration of renal clear cell carcinoma 786-O cells].
    Jin B; Gao L; Li W; Chen JC; Wen RM; Wang JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):166-171. PubMed ID: 28316213
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer.
    Nishikawa R; Goto Y; Sakamoto S; Chiyomaru T; Enokida H; Kojima S; Kinoshita T; Yamamoto N; Nakagawa M; Naya Y; Ichikawa T; Seki N
    Cancer Sci; 2014 Jul; 105(7):802-11. PubMed ID: 24815849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LASP1 in Tumor and Tumor Microenvironment.
    Hu Z; Wang X; Cui Y; Li C; Wang S
    Curr Mol Med; 2017; 17(8):541-548. PubMed ID: 29473505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. δEF1 promotes osteolytic metastasis of MDA-MB-231 breast cancer cells by regulating MMP-1 expression.
    Hu F; Wang C; Guo S; Sun W; Mi D; Gao Y; Zhang J; Zhu T; Yang S
    Biochim Biophys Acta; 2011 Mar; 1809(3):200-10. PubMed ID: 21241837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LIM and SH3 protein 1 induces TGFβ-mediated epithelial-mesenchymal transition in human colorectal cancer by regulating S100A4 expression.
    Wang H; Shi J; Luo Y; Liao Q; Niu Y; Zhang F; Shao Z; Ding Y; Zhao L
    Clin Cancer Res; 2014 Nov; 20(22):5835-47. PubMed ID: 25252758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway.
    Zhou R; Shao Z; Liu J; Zhan W; Gao Q; Pan Z; Wu L; Xu L; Ding Y; Zhao L
    Int J Cancer; 2018 May; 142(9):1853-1864. PubMed ID: 29226323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LIM and SH3 protein 1 (Lasp1) is a novel p53 transcriptional target involved in hepatocellular carcinoma.
    Wang B; Feng P; Xiao Z; Ren EC
    J Hepatol; 2009 Mar; 50(3):528-37. PubMed ID: 19155088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional inhibition of matrix metalloproteinase 9 (MMP-9) activity by a c-fos/estrogen receptor fusion protein is mediated by the proximal AP-1 site of the MMP-9 promoter and correlates with reduced tumor cell invasion.
    Crowe DL; Brown TN
    Neoplasia; 1999 Oct; 1(4):368-72. PubMed ID: 10935492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-133a acts as a tumour suppressor in breast cancer through targeting LASP1.
    Sui Y; Zhang X; Yang H; Wei W; Wang M
    Oncol Rep; 2018 Feb; 39(2):473-482. PubMed ID: 29207145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing the low lipid phosphate phosphatase 1 activity in breast cancer cells decreases transcription by AP-1 and expressions of matrix metalloproteinases and cyclin D1/D3.
    Tang X; McMullen TPW; Brindley DN
    Theranostics; 2019; 9(21):6129-6142. PubMed ID: 31534541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA LINC01207 promotes prostate cancer progression by downregulating microRNA-1972 and upregulating LIM and SH3 protein 1.
    Wang S; Qiu J; Wang L; Wu Z; Zhang X; Li Q; Jiang F
    IUBMB Life; 2020 Sep; 72(9):1960-1975. PubMed ID: 32726517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LASP1 is a HIF1α target gene critical for metastasis of pancreatic cancer.
    Zhao T; Ren H; Li J; Chen J; Zhang H; Xin W; Sun Y; Sun L; Yang Y; Sun J; Wang X; Gao S; Huang C; Zhang H; Yang S; Hao J
    Cancer Res; 2015 Jan; 75(1):111-9. PubMed ID: 25385028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetically regulated miR-145 suppresses colon cancer invasion and metastasis by targeting LASP1.
    Wang W; Ji G; Xiao X; Chen X; Qin WW; Yang F; Li YF; Fan LN; Xi WJ; Huo Y; Wen WH; Yang AG; Wang T
    Oncotarget; 2016 Oct; 7(42):68674-68687. PubMed ID: 27626692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of LASP1 is associated with proliferation, migration and invasion in esophageal squamous cell carcinoma.
    He B; Yin B; Wang B; Chen C; Xia Z; Tang J; Yuan Y; Feng X; Yin N
    Oncol Rep; 2013 Mar; 29(3):1115-23. PubMed ID: 23254782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.